MEDULLOSSEINUM (Seroyal USA)
Welcome to the PulseAid listing for the MEDULLOSSEINUM drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Seroyal USA |
| NON-PROPRIETARY NAME: | Bone marrow |
| SUBSTANCE NAME: | ORYCTOLAGUS CUNICULUS BONE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | GRANULE |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2015-07-22 |
| END MARKETING DATE: | 0000-00-00 |
MEDULLOSSEINUM HUMAN OTC DRUG Details:
| Item Description | MEDULLOSSEINUM from Seroyal USA |
| LABELER NAME: | Seroyal USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6([hp_X]/1) |
| START MARKETING DATE: | 2015-07-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62106-7086_1b7e7fd3-9352-1424-e054-00144ff88e88 |
| PRODUCT NDC: | 62106-7086 |
| APPLICATION NUMBER: | |
Other ORYCTOLAGUS CUNICULUS BONE Pharmaceutical Manufacturers / Labelers:
